“…Although we did not perform dose-response or antagonist studies to provide definitive demonstration that the effects are mediated through  2 ARs within the developing brain, the fact that the pattern of alterations mirrors the regional and temporal distribution of the receptors, incorporates the known consequences of AR overstimulation on cell replication and cell death, and parallels the effects of terbutaline on cell signaling all point to a receptor-mediated origin (Joseph et al, 1983;Lorton et al, 1988;Erdtsieck-Ernste et al, 1991;Teerlink et al, 1994;Hodges-Savola et al, 1996;Communal et al, 1998;Shizukuda et al, 1998;Gu et al, 2000;Yan et al, 2000;Singh et al, 2001;Slotkin et al, 2001Slotkin et al, , 2003Garofolo et al, 2003). Using neuroprotein biomarkers for astroglia (GFAP) and proximal neuronal projections (NF68), we obtained patterns that are typical of neuronal damage and reactive gliosis: initial increases in GFAP that eventually resolve and are replaced by elevated NF68, which is associated with reactive sprouting in response to injury (O'Callaghan, 1988;Schroeder et al, 2003). There are two important features of the alterations in neuroproteins.…”